Narasimhan, who took over as CEO in February, is emphasising the role of digital technology in helping Novartis come up with winning new therapies
Novartis's arrangement to pay only if patients respond to the drug as a huge breakthrough
The Swiss drugmaker expands its pipeline of medicines to combat blood diseases